Mielóma multiplex: vizsgálatok itt: Grúzia

1 trial · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.

• 1. fázisTaking people
  A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma

  Where

  Tbilisi

  Életkor

  18 év and over

  People

  258 worldwide

  Run by

  Shanghai Henlius Biotech

  See details and how to joinNCT07477587